Howard Hughes Medical Institute Albemarle Corp Transaction History
Howard Hughes Medical Institute
- $250 Million
- Q2 2025
A detailed history of Howard Hughes Medical Institute transactions in Albemarle Corp stock. As of the latest transaction made, Howard Hughes Medical Institute holds 25 shares of ALB stock, worth $2,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$2,205% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALB
# of Institutions
856Shares Held
116MCall Options Held
7.46MPut Options Held
14.4M-
Vanguard Group Inc Valley Forge, PA14.7MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY9.96MShares$879 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA8.24MShares$727 Million0.08% of portfolio
-
State Street Corp Boston, MA6.64MShares$586 Million0.02% of portfolio
-
Franklin Resources Inc San Mateo, CA5.77MShares$509 Million0.1% of portfolio
About ALBEMARLE CORP
- Ticker ALB
- Exchange NYSE
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 117,129,000
- Market Cap $10.3B
- Description
- Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...